CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT06208735 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Leukemia
Non-Hodgkin's Lymphoma
B-cell Acute Lymphoblastic Leukemia
Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Mantle Cell Lymphoma
B-cell Lymphoma

Interventions

BIOLOGICAL: CLIC-2201

Sponsor

British Columbia Cancer Agency